 |
FDA Approval Activities for this Drug
EMEND (Aprepitant) Capsules, Merck & Company, NDA 21-549 EMEND (Aprepitant) Capsules, Merck & Company, Inc. | Emend (aprepitant) Capsules, Merck & Co., Labeling Revision | Emend (aprepitant) Capsules, Merck & Co., Labeling Revision | Emend (Aprepitant) Capsules, Merck & Co., New or Modified Indication | Emend (aprepitant) Capsules, Merck and Co., Labeling Revision | EMEND (aprepitant) Capsules, Merck & Co. Inc., Labeling Revision | Emend (aprepitant) Capsules, Merck & Co., Inc., Labeling Revision | EMEND (aprepitant) Capsules, Merck & Co., Inc., Labeling Revision | Emend (aprepitant) Capsules, Merck & Co., Inc., Labeling Revision | Emend (aprepitant) Capsules, Merck Sharp & Dohme Corp., Efficacy Supplement with Clinical Data to Support
View updates.
|